AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2013
Dec 4, 2013
32853_dirs_2013-12-04_f39efb8d-4fb9-48da-b98f-2513059db9a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-12-02
Reporting Person: Smith William Maxwell (EVP, LEGAL AFFAIRS & GC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-02 | Common Stock | M | 1637 | $4.4461 | Acquired | 1637 | Direct |
| 2013-12-02 | Common Stock | M | 3336 | $8.3732 | Acquired | 4973 | Direct |
| 2013-12-02 | Common Stock | M | 2000 | $14.60 | Acquired | 6973 | Direct |
| 2013-12-02 | Common Stock | M | 1250 | $15.49 | Acquired | 8223 | Direct |
| 2013-12-02 | Common Stock | S | 8223 | $32.1007 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-12-02 | Employee Stock Option (Right to Buy) | $4.4461 | M | 1637 | Disposed | 2018-04-23 | Common | |
| Stock (1637) | Direct | |||||||
| 2013-12-02 | Employee Stock Option (Right to Buy) | $8.3732 | M | 3336 | Disposed | 2021-01-04 | Common | |
| Stock (3336) | Direct | |||||||
| 2013-12-02 | Employee Stock Option (Right to Buy) | $14.60 | M | 2000 | Disposed | 2021-05-17 | Common | |
| Stock (2000) | Direct | |||||||
| 2013-12-02 | Employee Stock Option (Right to Buy) | $15.49 | M | 1250 | Disposed | 2022-02-17 | Common | |
| Stock (1250) | Direct |
Footnotes
F1: The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on November 28, 2012.
F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $31.935 to $32.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3: The shares subject to the Option fully vested on May 1, 2008.
F4: 70% of the shares subject to the Option vested on March 10, 2011, 25% of the remaining 30% of the shares subject to the Option vested on April 1, 2011 and 1/48 of the remaining unvested shares subject to the Option vest each month thereafter, such that the Option will be fully vested on April 1, 2014.
F5: 1/48th of the shares subject to the Option vested on June 18, 2011 and 1//8th of the shares subject to the Option vest each month thereafter, such that the Option will be fully vested on May 18, 2015.
F6: 1/48 of the shares subject to the Option vested on February 17, 2012 and 1/48 of the shares subject to the Option vested on March 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.